Market Cap 174.43M
Revenue (ttm) 31.08M
Net Income (ttm) -200.40M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -644.79%
Debt to Equity Ratio 0.69
Volume 8,266,600
Avg Vol 18,083,191
Day's Range N/A - N/A
Shares Out 246.24M
Stochastic %K 72%
Beta 1.02
Analysts Sell
Price Target $2.60

Latest News on LXRX

Top 2 Health Care Stocks That May Crash This Month

Apr 25, 2025, 9:00 AM EDT - 1 day ago

Top 2 Health Care Stocks That May Crash This Month


Lexicon Appoints Scott Coiante as Chief Financial Officer

Jan 2, 2025, 8:00 AM EST - 4 months ago

Lexicon Appoints Scott Coiante as Chief Financial Officer


US FDA declines to approve Lexicon Pharma's add-on diabetes drug

Dec 20, 2024, 4:46 PM EST - 4 months ago

US FDA declines to approve Lexicon Pharma's add-on diabetes drug


Lexicon Appoints Ivan H. Cheung to Board of Directors

Nov 20, 2024, 4:05 PM EST - 5 months ago

Lexicon Appoints Ivan H. Cheung to Board of Directors


Lexicon Pharmaceuticals to Host 2024 Investor Day

Apr 18, 2024, 8:00 AM EDT - 1 year ago

Lexicon Pharmaceuticals to Host 2024 Investor Day